Literature DB >> 31221700

Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery.

Klemen Dovc1,2, Charlotte Boughton1, Martin Tauschmann1,3, Hood Thabit1,4, Lia Bally1,5, Janet M Allen1,6, Carlo L Acerini1,6, Sabine Arnolds7, Carine de Beaufort8, Richard M Bergenstal9, Fiona Campbell10, Amy Criego9, David B Dunger1,6, Daniella Elleri11, Mark L Evans1,12, Elke Fröhlich-Reiterer13, Sabine Hofer14, Thomas Kapellen15, Lalantha Leelarathna4, Thomas R Pieber16, Birgit Rami-Merhar3, Viral N Shah17, Judy Sibayan18, Malgorzata E Wilinska1,6, Roman Hovorka19,6.   

Abstract

OBJECTIVE: To quantify age-related variability of insulin needs during day and night closed-loop insulin delivery. RESEARCH DESIGN AND METHODS: We retrospectively analyzed data from hybrid closed-loop studies involving young children (1-6 years old, n = 20), children (7-12 years, n = 21), adolescents (13-17 years, n = 15), and adults (>18 years, n = 58) with type 1 diabetes. The coefficient of variation quantified variability of insulin needs during 3 weeks of unrestricted-living hybrid closed-loop use.
RESULTS: Data from 2,365 nights and 2,367 days in 114 participants were analyzed. The coefficient of variation of insulin delivery was higher in young children compared with adults (mean difference at nighttime 10.7 percentage points [95% CI 2.9-18.4], P = 0.003; daytime 6.4 percentage points [95% CI 2.0-10.9], P = 0.002) and compared with adolescents (mean difference at nighttime 10.2 percentage points [95% CI 0.0-20.4], P = 0.049; daytime 7.0 percentage points [95% CI 1.1-12.8], P = 0.014).
CONCLUSIONS: Diabetes management in young children is complicated by higher variability in insulin requirements, supporting fast-track clinical practice adoption of closed-loop in this vulnerable population.
© 2019 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31221700      PMCID: PMC6609966          DOI: 10.2337/dc18-2625

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  12 in total

1.  Clinical presentation and autoimmune characteristics of very young children at the onset of type 1 diabetes mellitus.

Authors:  Carla Bizzarri; Danila Benevento; Paolo Ciampalini; Patrizia Patera Ippolita; Riccardo Schiaffini; Antonella Migliaccio; Lucilla Ravà; Marco Cappa
Journal:  J Pediatr Endocrinol Metab       Date:  2010-11       Impact factor: 1.634

2.  Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes.

Authors:  Michelle A Van Name; Marisa E Hilliard; Claire T Boyle; Kellee M Miller; Daniel J DeSalvo; Barbara J Anderson; Lori M Laffel; Stephanie E Woerner; Linda A DiMeglio; William V Tamborlane
Journal:  Pediatr Diabetes       Date:  2017-04-21       Impact factor: 4.866

Review 3.  Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.

Authors:  Alanna Weisman; Johnny-Wei Bai; Marina Cardinez; Caroline K Kramer; Bruce A Perkins
Journal:  Lancet Diabetes Endocrinol       Date:  2017-05-19       Impact factor: 32.069

4.  Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial.

Authors:  Martin Tauschmann; Janet M Allen; Katrin Nagl; Maria Fritsch; James Yong; Emily Metcalfe; Dominique Schaeffer; Muriel Fichelle; Ulrike Schierloh; Alena G Thiele; Daniela Abt; Harald Kojzar; Julia K Mader; Sonja Slegtenhorst; Nicole Barber; Malgorzata E Wilinska; Charlotte Boughton; Gianluca Musolino; Judy Sibayan; Nathan Cohen; Craig Kollman; Sabine E Hofer; Elke Fröhlich-Reiterer; Thomas M Kapellen; Carlo L Acerini; Carine de Beaufort; Fiona Campbell; Birgit Rami-Merhar; Roman Hovorka
Journal:  Diabetes Care       Date:  2019-01-28       Impact factor: 19.112

5.  Variability of Insulin Requirements Over 12 Weeks of Closed-Loop Insulin Delivery in Adults With Type 1 Diabetes.

Authors:  Yue Ruan; Hood Thabit; Lalantha Leelarathna; Sara Hartnell; Malgorzata E Willinska; Sibylle Dellweg; Carsten Benesch; Julia K Mader; Manuel Holzer; Harald Kojzar; Mark L Evans; Thomas R Pieber; Sabine Arnolds; Roman Hovorka
Journal:  Diabetes Care       Date:  2016-03-10       Impact factor: 19.112

6.  Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial.

Authors:  Martin Tauschmann; Janet M Allen; Malgorzata E Wilinska; Hood Thabit; Carlo L Acerini; David B Dunger; Roman Hovorka
Journal:  Diabetes Care       Date:  2016-09-09       Impact factor: 19.112

7.  Daily insulin requirement of children and adolescents with type 1 diabetes: effect of age, gender, body mass index and mode of therapy.

Authors:  Susanna Wiegand; Klemens Raile; Thomas Reinehr; Sabine Hofer; Andrea Näke; Wolfgang Rabl; Reinhard W Holl
Journal:  Eur J Endocrinol       Date:  2008-04       Impact factor: 6.664

Review 8.  Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.

Authors:  Eleni Bekiari; Konstantinos Kitsios; Hood Thabit; Martin Tauschmann; Eleni Athanasiadou; Thomas Karagiannis; Anna-Bettina Haidich; Roman Hovorka; Apostolos Tsapas
Journal:  BMJ       Date:  2018-04-18

9.  Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.

Authors:  Martin Tauschmann; Hood Thabit; Lia Bally; Janet M Allen; Sara Hartnell; Malgorzata E Wilinska; Yue Ruan; Judy Sibayan; Craig Kollman; Peiyao Cheng; Roy W Beck; Carlo L Acerini; Mark L Evans; David B Dunger; Daniela Elleri; Fiona Campbell; Richard M Bergenstal; Amy Criego; Viral N Shah; Lalantha Leelarathna; Roman Hovorka
Journal:  Lancet       Date:  2018-10-03       Impact factor: 202.731

10.  Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.

Authors:  Wei Hao; Steven Gitelman; Linda A DiMeglio; David Boulware; Carla J Greenbaum
Journal:  Diabetes Care       Date:  2016-07-15       Impact factor: 19.112

View more
  7 in total

Review 1.  Recent advances in closed-loop insulin delivery.

Authors:  Julia Ware; Roman Hovorka
Journal:  Metabolism       Date:  2021-12-07       Impact factor: 8.694

Review 2.  Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy.

Authors:  Julia Fuchs; Roman Hovorka
Journal:  Expert Rev Med Devices       Date:  2020-07-03       Impact factor: 3.166

3.  Diabetes Technology Use in Remote Pediatric Patients with Type 1 Diabetes Using Clinic-to-Clinic Telemedicine.

Authors:  Erin C Cobry; Tyler Reznick-Lipina; Laura Pyle; Robert Slover; John F Thomas; Guy Todd Alonso; Raj Paul Wadwa
Journal:  Diabetes Technol Ther       Date:  2022-01       Impact factor: 6.118

4.  Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol.

Authors:  Julia Fuchs; Janet M Allen; Charlotte K Boughton; Malgorzata E Wilinska; Ajay Thankamony; Carine de Beaufort; Fiona Campbell; James Yong; Elke Froehlich-Reiterer; Julia K Mader; Sabine E Hofer; Thomas M Kapellen; Birgit Rami-Merhar; Martin Tauschmann; Korey Hood; Barbara Kimbell; Julia Lawton; Stephane Roze; Judy Sibayan; Nathan Cohen; Roman Hovorka
Journal:  BMJ Open       Date:  2021-02-12       Impact factor: 2.692

5.  Training and Support for Hybrid Closed-Loop Therapy.

Authors:  Charlotte K Boughton; Sara Hartnell; Janet M Allen; Julia Fuchs; Roman Hovorka
Journal:  J Diabetes Sci Technol       Date:  2020-09-11

6.  Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate): A multinational prospective observational real-world cohort study.

Authors:  Klemen Dovc; Michelle Van Name; Barbara Jenko Bizjan; Ewa Rusak; Claudia Piona; Gul Yesiltepe-Mutlu; Rosaline Mentink; Giulio Frontino; Maddalena Macedoni; Sofia Helena Ferreira; Joana Serra-Caetano; Júlia Galhardo; Julie Pelicand; Francesca Silvestri; Jennifer Sherr; Agata Chobot; Torben Biester
Journal:  Diabetes Obes Metab       Date:  2021-12-27       Impact factor: 6.408

7.  Glycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial.

Authors:  Gregory P Forlenza; Laya Ekhlaspour; Linda A DiMeglio; Larry A Fox; Henry Rodriguez; Dorothy I Shulman; Kevin B Kaiserman; David R Liljenquist; John Shin; Scott W Lee; Bruce A Buckingham
Journal:  Pediatr Diabetes       Date:  2022-01-31       Impact factor: 3.409

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.